Literature DB >> 21546251

Plastin 3 expression in discordant spinal muscular atrophy (SMA) siblings.

Sara Bernal1, Eva Also-Rallo, Rebeca Martínez-Hernández, Laura Alías, Francisco Javier Rodríguez-Alvarez, José M Millán, Concepción Hernández-Chico, Montserrat Baiget, Eduardo F Tizzano.   

Abstract

Spinal muscular atrophy (SMA) is caused by loss or mutations of the survival motor neuron 1 gene (SMN1). Its highly homologous copy, SMN2, is present in all SMA cases and is a phenotypic modifier. There are cases where asymptomatic siblings of typical SMA patients possess a homozygous deletion of SMN1 just like their symptomatic brothers or sisters. Plastin 3 (PLS3) when over expressed in lymphoblasts from females has been suggested to act as a genetic modifier of SMA. We studied PLS3 expression in four Spanish SMA families with discordant siblings haploidentical for the SMA locus. We excluded PLS3 as a possible modifier in two of our families with female discordant siblings. In the remaining two, we observed small differences in PLS3 expression between male and female discordant siblings. Indeed, we found that values of PLS3 expression in lymphoblasts and peripheral blood ranged from 12 to 200-fold less than those in fibroblasts. These findings warrant further investigation in motor neurons derived from induced pluripotential stem cells of these patients.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21546251     DOI: 10.1016/j.nmd.2011.03.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  22 in total

Review 1.  Disease mechanisms and therapeutic approaches in spinal muscular atrophy.

Authors:  Sarah Tisdale; Livio Pellizzoni
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

2.  The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype.

Authors:  Seyyedmohsen Hosseinibarkooie; Miriam Peters; Laura Torres-Benito; Raphael H Rastetter; Kristina Hupperich; Andrea Hoffmann; Natalia Mendoza-Ferreira; Anna Kaczmarek; Eva Janzen; Janine Milbradt; Tobias Lamkemeyer; Frank Rigo; C Frank Bennett; Christoph Guschlbauer; Ansgar Büschges; Matthias Hammerschmidt; Markus Riessland; Min Jeong Kye; Christoph S Clemen; Brunhilde Wirth
Journal:  Am J Hum Genet       Date:  2016-08-04       Impact factor: 11.025

Review 3.  Spinal muscular atrophy: diagnosis and management in a new therapeutic era.

Authors:  W David Arnold; Darine Kassar; John T Kissel
Journal:  Muscle Nerve       Date:  2014-12-16       Impact factor: 3.217

Review 4.  Spinal muscular atrophy: the role of SMN in axonal mRNA regulation.

Authors:  Claudia Fallini; Gary J Bassell; Wilfried Rossoll
Journal:  Brain Res       Date:  2012-01-28       Impact factor: 3.252

5.  Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype.

Authors:  Corey Ruhno; Vicki L McGovern; Matthew R Avenarius; Pamela J Snyder; Thomas W Prior; Flavia C Nery; Abdurrahman Muhtaseb; Jennifer S Roggenbuck; John T Kissel; Valeria A Sansone; Jennifer J Siranosian; Alec J Johnstone; Pann H Nwe; Ren Z Zhang; Kathryn J Swoboda; Arthur H M Burghes
Journal:  Hum Genet       Date:  2019-02-20       Impact factor: 4.132

6.  Survival motor neuron affects plastin 3 protein levels leading to motor defects.

Authors:  Le T Hao; Marc Wolman; Michael Granato; Christine E Beattie
Journal:  J Neurosci       Date:  2012-04-11       Impact factor: 6.167

7.  Plastin 3 is upregulated in iPSC-derived motoneurons from asymptomatic SMN1-deleted individuals.

Authors:  Ludwig Heesen; Michael Peitz; Laura Torres-Benito; Irmgard Hölker; Kristina Hupperich; Kristina Dobrindt; Johannes Jungverdorben; Swetlana Ritzenhofen; Beatrice Weykopf; Daniela Eckert; Seyyed Mohsen Hosseini-Barkooie; Markus Storbeck; Noemi Fusaki; Renata Lonigro; Raoul Heller; Min Jeong Kye; Oliver Brüstle; Brunhilde Wirth
Journal:  Cell Mol Life Sci       Date:  2015-11-16       Impact factor: 9.261

8.  Association between SMN2 methylation and disease severity in Chinese children with spinal muscular atrophy.

Authors:  Yan-yan Cao; Yu-jin Qu; Sheng-xi He; Yan Li; Jin-Ll Bai; Yu-wei Jin; Hong Wang; Fang Song
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

9.  A rare variant (c.863G>T) in exon 7 of SMN1 disrupts mRNA splicing and is responsible for spinal muscular atrophy.

Authors:  Yu-Jin Qu; Jin-Li Bai; Yan-Yan Cao; Wen-Hui Zhang; Hong Wang; Yu-Wei Jin; Fang Song
Journal:  Eur J Hum Genet       Date:  2015-09-30       Impact factor: 4.246

Review 10.  Spinal muscular atrophy: development and implementation of potential treatments.

Authors:  W David Arnold; Arthur H M Burghes
Journal:  Ann Neurol       Date:  2013-09       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.